Related Experiment Video
Updated: Feb 14, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
FGFR Testing in Metastatic Urothelial Carcinoma-Who, When, and How to Test
André Mansinho1,2, José Carlos Machado3,4,5, Cátia Faustino6
1START Lisbon, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, 1649-035 Lisbon, Portugal.
Accurate FGFR3 testing is crucial for selecting patients with metastatic urothelial carcinoma (mUC) for targeted therapies like erdafitinib. Standardizing this molecular profiling ensures optimal treatment planning for improved outcomes in mUC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastatic urothelial carcinoma (mUC) presents limited treatment options.
- Genomic research has identified actionable molecular targets in mUC.
- Fibroblast growth factor receptor 3 (FGFR3) alterations are key drivers in bladder cancer.
Purpose of the Study:
- To review key considerations for FGFR3 testing in mUC.
- To discuss the routine incorporation of FGFR3 testing into clinical practice.
- To highlight the importance of molecular profiling for guiding FGFR inhibitor therapy.
Main Methods:
- Review of genomic and transcriptomic research in mUC.
- Analysis of clinical trial data, including the THOR trial.
- Discussion of molecular profiling techniques and standardization.
Main Results:
- FGFR3 alterations are predictive biomarkers for FGFR inhibitor response.
- Erdafitinib demonstrated clinical benefit in previously treated mUC patients with FGFR3 alterations.
- Accurate and timely FGFR3 testing is essential for patient selection.
Conclusions:
- FGFR3 testing is critical for optimizing treatment with FGFR inhibitors in mUC.
- Standardization of FGFR3 testing is needed for clinical practice.
- Molecular profiling advances have expanded therapeutic options for mUC.
More Related Videos
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Significance Testing: Overview
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Testing Water Quality
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...